SEC Form 4 · accession 0001225208-18-011637

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Donald E Bobo Jr.

Officer — CVP,Strategy/Corp Development

Period of report

Jul 11, 2018

Accepted (ET)

Jul 12, 2018 · 7:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Jul 11, 2018	M	5,500	$42.725	A	25,565	D
Common Stock	Jul 11, 2018	S	5,500	$145.57	D	20,065	D
Common Stock	holding	—	—		—	12,544	I	401(k)
Common Stock	holding	—	—		—	50,785	I	By Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Acquire)	$42.725	Jul 11, 2018	M	5,500	D	May 9, 2012	May 8, 2019	Common Stock	5,500	44,600	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018.
F2This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator

Remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.